Malaria Vaccine Adjuvants: Latest Update and Challenges in Preclinical and Clinical Research

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Immunostimulants</td><td align="left">Delivery systems</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Saponins <br/>Polysaccharides <br/>TLR ligands <br/>Cytokines</td><td align="left">Alum <br/>Emulsions  <br/>Liposomes <br/>ISCOMs <br/>Polymeric particles <br/>Virosomes <br/>VLPs <br/>Viral vectors</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Classification of adjuvants by their principal mechanism of action.

BioMed Research International

tab1

Table 1

Table 1: Malaria Vaccine Adjuvants: Latest Update and Challenges in Preclinical and Clinical Research 